Table 1 Comparison of population characteristics for pilot vs. non-pilot and pilot HPV vs. pilot LBC areas. Pilot areas were defined using the 2013–2015 definition. The comparison of HPV and LBC pilot areas was based on four laboratory sites
Indicator | Pilot (weighted mean, SD) | Non-pilot (weighted mean, SD) | Difference pilot vs. non-pilot (95% CI) | HPV testing (weighted mean, SD) | LBC (weighted mean, SD) | Difference HPV vs. LBC (95% CI) | National range (min–max per CCG) |
|---|---|---|---|---|---|---|---|
IMD score | 24.8 (7.3) | 21.3 (8.1) | 3.4 (0.2 to 6.6) | 24.2 (6.3) | 27.4 (7.3) | -3.2 (-9.1 to 3.2) | 5.7–51.6 |
Smoking prevalence | 19.1 (2.8) | 18.3 (2.6) | 0.8 (-0.3 to 1.9) | 18.4 (2.3) | 19.7 (3.1) | -1.3 (-3.3 to 1.3) | 12.3–27.1 |
Cervical screening coverage | 72.7 (4.3) | 73.8 (3.9) | -1.2 (-3.1 to 0.6) | 73.5 (3.4) | 71.0 (4.9) | 2.5 (-1.7 to 5.9) | 56.8–83.1 |
HPV vaccination | 83.9 (8.1) | 83.7 (6.8) | 0.2 (-4.6 to 4.0) | 56.7–96.7 | |||
Incidence of STI per 100,000 | 784.1 (309.3) | 801.6 (516.6) | -17.4 (-180.3 to 170.8) | 365.0–3475.0 | |||
Incidence of cervical cancer per 100,000 | 10.6 (2.8) | 9.8 (2.1) | 0.9 (-0.6 to 2.1) | 4.60–16.6 | |||
Satisfaction with GP surgery | 72.7 (3.2) | 73.4 (4.8) | -0.7 (-2.7 to 1.0) | 58.6–96.7 |